Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Michael L. Mohler"'
Autor:
Michael L. Mohler, Ramesh Narayanan, Duane D. Miller, Dong Jin Hwang, Yali He, Thirumagal Thiyagarajan, Suriyan Ponnusamy
Publikováno v:
J Med Chem
A series of propanamide derivatives were designed, synthesized, and pharmacologically characterized as selective androgen receptor degraders (SARDs) and pan-antagonists that exert a broad-scope androgen receptor (AR) antagonism. Incorporating differe
Autor:
Michael L. Mohler, James T. Dalton
Publikováno v:
Burger's Medicinal Chemistry and Drug Discovery
Autor:
Suriyan Ponnusamy, Duane D. Miller, Dong Jin Hwang, Ramesh Narayanan, Michael L. Mohler, Yali He, Arunima Sikdar
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2124, p 2124 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Traditional endocrine therapy for prostate cancer (PCa) has been directed at suppression of the androgen receptor (AR) signaling axis since Huggins et al. discovered that diethylstilbestrol (DES; an estrogen) produced chemical castration and PCa tumo
Autor:
Ramesh Narayanan, Muralimohan Yepuru, Christopher C Coss, Zhongzhi Wu, Matthew N Bauler, Christina M Barrett, Michael L Mohler, Yun Wang, Juhyun Kim, Linda M Snyder, Yali He, Nelson Levy, Duane D Miller, James T Dalton
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83380 (2013)
Receptor tyrosine kinases (RTKs), in response to their growth factor ligands, phosphorylate and activate downstream signals important for physiological development and pathological transformation. Increased expression, activating mutations and rearra
Externí odkaz:
https://doaj.org/article/99a4bb75c3cc4be7b28f17e6807eb989
Autor:
Duane D. Miller, Michael L. Mohler, Dong Jin Hwang, Yali He, Thirumagal Thiyagarajan, Ramesh Narayanan, Suriyan Ponnusamy
Publikováno v:
J Med Chem
We report herein the design, synthesis, and pharmacological characterization of a library of novel aryl pyrazol-1-yl-propanamides as selective androgen receptor degraders (SARDs) and pan-antagonists that exert broad-scope AR antagonism. Pharmacologic
Autor:
Duane D. Miller, Suriyan Ponnusamy, Ramesh Narayanan, Dong Jin Hwang, Thirumagal Thiyagarajan, Michael L. Mohler, Yali He, Iain J. McEwan
Publikováno v:
Journal of medicinal chemistry. 62(2)
In our effort to find small-molecule treatments of advanced prostate cancers (PCs), a novel series of indolyl and indolinyl propanamides (series II and III) were discovered as selective androgen receptor degraders (SARDs). Initial studies of androgen
Autor:
Chien-Ming Li, Jianjun Chen, Michael L. Mohler, Wei Li, Zhao Wang, James T. Dalton, Yan Lu, Duane D. Miller
Publikováno v:
Journal of Medicinal Chemistry. 54:4678-4693
In a continued effort to improve upon the previously published 4-substituted methoxybenzoyl-aryl-thiazole (SMART) template, we explored chemodiverse "B" rings and "B" to "C" ring linkage. Further, to overcome the poor aqueous solubility of this serie
Autor:
Ramesh Narayanan, Yali He, Christopher C. Coss, Michael L. Mohler, Kejiang Hu, Zhongzhi Wu, Duane D. Miller, Seoung-Soo Hong, James T. Dalton, Dong Jin Hwang
Publikováno v:
Expert Opinion on Therapeutic Patents. 20:507-534
Nonsteroidal estrogens have been known since the 1930s. However, the relatively recent (1996) discovery of estrogen receptor subtype beta (ERbeta) suggested a possible paradigm shift away from SERM-like selectivity. Selective ERbeta agonism would pot
Autor:
Michael L. Mohler, Christopher C. Coss, Miller Duane D, James T. Dalton, Dong Jin Hwang, Casey E. Bohl, Amanda Jones, Yali He, Ramesh Narayanan
Publikováno v:
Journal of Medicinal Chemistry. 52:3597-3617
Interest in the development and therapeutic potential of nonsteroidal tissue-selective androgen receptor modulators (SARMs) has increased dramatically within the past decade. Rapidly expanding knowledge of nuclear hormone receptor structure and funct
Publikováno v:
Medicinal Research Reviews. 29:125-195
Diabetes is a disease that affects over 150 million people worldwide for which there are multiple oral and injectable medications. Because of trends in obesity and sedentary lifestyles, diabetes rates in both developed and developing countries are in